Archive for September, 2010

Nestle Expands Into Personalized Nutrition

Posted on September 28, 2010 by

The Nestle Institute of Health Sciences will be part of the organization’s R&D network which will conduct research into how nutritional strategies improve health and longevity. The Institute will be based at Ecole Polytechnique Federale de Lausanne (Swiss Federal Institute of Technology at Lausanne) and be run by Emmanuel E. Baetge, former Chief Scientific Officer […]

Continue Reading

First Multiple Sclerosis Pill approved by FDA

Posted on September 28, 2010 by

Last week, Novartis received FDA approval to market the once a day pill Gilenya, a sphingosine 1-phosphate receptor modulator for treatment of multiple sclerosis. Other MS treatments require injection. The precise mechanism of action is not understood in MS but seems to act by reducing the release of white cells from lymph nodes thereby reducing […]

Continue Reading

STUDIES: SIGNIFICANT HEALTH BENEFITS OF COFFEE

Posted on September 21, 2010 by

Coffee is now being studied more closely by researchers who are seeing potential for significant disease prevention and therapeutics. They are trying to understand how the coffee and caffeine actually work within the cells as population studies show promise for therapeutics. Harvard researchers have done a study which indicates that drinking 1-3 cups of caffeinated […]

Continue Reading

Walmart retail clinics-new opportunity for hospitals

Posted on September 20, 2010 by

Local hospitals and hospital systems are expanding by agreeing to run clinics at Walmarts in their communities. Walmart is planning to put in over 2000 health clinics. So far, nearly half the retail clinics are located in the most populous states, California, Florida, Illinois, Minnesota and Texas. Clinical services include: Treatment for acne, bladder infections, […]

Continue Reading

COMPANY: SHARING DATA = BETTER CONTROL OF CHRONIC DISEASE

Posted on September 12, 2010 by

A unique company in Cambridge Ma. has created a comprehensive social networking web site community for individuals with specific illnesses and their family members. The company Patientslikeme.com offers information about the latest treatments and the creation of a database of voluntary contributors on the benefits of certain treatments as well as the detriments. It is […]

Continue Reading

Cranberry juice Shows Promise In Blocking Staph Infections

Posted on September 5, 2010 by

Researchers as Worcester Polytech have reported strong findings from a small clinical study that cranberry juice blocks a strain of Staphylococcus aureus from beginning the process of infection in lab studies. Urine samples from subjects who had recently consumed cranberry juice significantly reduced the ability of both S. auereus and E.coli to form on the […]

Continue Reading

Gleevec, Novartis Leukemia Drug Could Lead to Alzheimer’s Treatment If…

Posted on September 2, 2010 by

Some new research reported in the Journal Nature this week and highlighted in the New York Times, suggests that an existing drug used for leukemia could prevent the growth of beta amyloid, thought to cause Alzheimer’s disease. The problem is that when tested in animals, the drug Gleevec does not remain in the brain long […]

Continue Reading

MIT Computer Scientist Creates Algorithms for Better Drug Designs

Posted on September 1, 2010 by

Shivani Agarwal, a Postdoc student in the Computer Science Dept at Harvard has created a new kind of algorithm that can predict a drugs’ success more reliably than those in current use. The difference is in how the algorithms measure the accuracy of the prediction about drugs. Traditional algorithms when predicting the accuracy of a […]

Continue Reading

Illegal Immigrants to Obtain Dialysis Care

Posted on September 1, 2010 by

Atlanta’s Grady Memorial Hospital has agreed to financially assist dialysis provider Fresenius to offer care to several illegal immigrants who are end-stage renal patients

Continue Reading
  •  
  •